Investor Presentaiton

Adjusted EBITDA at 110 crs Particulars Revenue EBITDA (Pre ESOP) One offs Improvement in Inventory days FY23 14,209 756 102 60 60 Business restructuring 29 Turkey earthquake impact 13 Hyper inflation 28 Discontinued Operations in Germany 217 Adjusted EBITDA 1103 Amt in Rs Mn J Sequent Proven Ability In Life Sciences ALIVIRA 10

View entire presentation